As reported on News-Medical, an experimental treatment for idiopathic pulmonary fibrosis (IPF), rentosertib, was associated with shifts toward younger biological age profiles across multiple protein-based
As reported on PharmaBiz, the U.S. Food and Drug Administration has accepted Takeda’s New Drug Application for the investigational oral therapy zasocitinib (TAK-279) and assigned
My name is Terri, and I live in the small town of Searcy, Arkansas, where I’ve proudly connected with countless people and their families over
As reported on Fierce Biotech, the U.S. Food and Drug Administration (FDA) has launched a new pilot program designed to streamline the investigational new drug
Editor’s Note: This story was originally written and submitted to us by Anthony Clark. “Okay, Michael, hold the ball up to your ear, then throw
The condition Dupuytren disease, also called Dupuytren contracture, is a chronic disorder of connective tissue in the palm. Tissue gradually becomes thickened and tight, forming
As reported on PharmaBiz, the US Food and Drug Administration (FDA) has authorized Acepodia to proceed with clinical testing of ACE723, an investigational antibody-drug conjugate
As reported on Fierce BioTech, a phase 3 study conducted by MediLink has delivered positive results for Roche-partnered antibody-drug conjugate (ADC) tambotatug pelitecan (tam-peli), also
What’s the Good News? Researchers have successfully completed initial testing of an experimental Parkinson’s medication called TT-P34. The early results are very encouraging and suggest
The history of cystinosis is one of the most successful examples of rare disease research leading to meaningful treatments. In a recent interview with the
This is my son Nikolai. Nikolai was recently diagnosed with Mucopolysaccharidosis type 2, or “Hunter Syndrome.” A rare genetic form of childhood dementia, it’s caused
As reported on PharmaBiz, a combination of Imfinzi (durvalumab) and Imdelltra (tarlatamab) has delivered significant improvements in survival outcomes for patients with extensive-stage small cell
At the age of 18, I was diagnosed with a rare swallowing disorder called Achalasia. At the time of this video, I had undergone several
In honor of World Duchenne Awareness Day on September 7th, Mal Duffin has invited us to share this app designed for parents whose children are living
As reported on World Pharma News, the U.S. Food and Drug Administration has granted approval to daraxonrasib, an oral RAS-targeting therapy, for adults with metastatic
A novel investigational Ebola vaccine has shown encouraging safety and immunogenicity results in a first-in-human clinical trial, supporting further development of an alternative vaccination strategy
Editor’s Note: Patient Worthy is honored to share this article, originally written by David St. Denis, President & Director at Anteris Technologies. Transcatheter aortic valve
Although Nancy Wexler’s efforts were largely responsible for creating a genetic test to locate the Huntington’s gene, she refused to take the test herself saying
Canadian Organization for Rare DisordersRegistration link: us02web.zoom.us/meeting/register/NR8q7yz1SE-ymSUIYAVZxA#/registration
My Personal Dictionary: SOON. ⏳
In everyday life, “soon” sounds simple. But in healthcare, it can mean waiting for a call, test results, answers, decisions, or the possibility of something new.
For a patient or caregiver, “soon” can feel very different depending on what you’re waiting for—and how much is riding on that answer.
Because sometimes, four little letters can hold a whole lot of uncertainty. 💛
#PatientAdvocacy #CaregiverSupport #PatientWorthy
When it comes to non-small cell lung cancer (NSCLC), knowledge can be a powerful tool. Biomarker testing can help identify genetic mutations, such as KRAS G12C, that may provide important information about a patient's cancer and help guide treatment decisions.
Testing may be performed using a tissue biopsy or a blood-based liquid biopsy, helping healthcare teams better understand the unique characteristics of each person's disease. Understanding your biomarker status can open the door to more personalized conversations about care and treatment options.
If you or a loved one has been diagnosed with NSCLC, with a KRAS G12C mutation, consider sharing your story today. Visit PatientWorthy.com
#NSCLC #KRASG12C #lungcancerawareness #BiomarkerTesting #shareyourstory #PatientWorthy #PatientEducation #lungcancercommunity #cancerawareness #PatientVoices
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
